Medicare Enrolled

Dr. Kristin Gowin, M.D.

Rheumatology · Asheville, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4 VANDERBILT PARK DR, Asheville, NC 28803
8282589533
In practice since 2006 (20 years)
NPI: 1033172895 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gowin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gowin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gowin

Dr. Kristin Gowin is a rheumatology specialist in Asheville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gowin performed 98,335 Medicare services across 3,434 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gowin received a total of $204,185 from 29 pharmaceutical and/or device companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gowin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 20% volume in NC $204,185 industry payments

Medicare Practice Summary

Medicare Utilization ↗
98,335
Medicare services
Top 20% in NC for rheumatology
3,434
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,917 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 54,200 $5 $11
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
19,530 $11 $30
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
6,675 $34 $75
Denosumab injection (Prolia/Xgeva) 4,800 $18 $40
Romosozumab injection (Evenity) for osteoporosis 4,200 $8 $17
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
1,390 $29 $110
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
745 $8 $43
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
721 $3 $30
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
720 $5 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
682 $85 $206
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
679 $5 $20
Liver function blood test panel 650 $8 $35
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
549 $8 $10
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
307 $98 $265
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
297 $11 $52
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
220 $60 $140
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
174 $1 $5
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
170 $6 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
162 $11 $36
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
154 $3 $27
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
154 $5 $22
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
138 $47 $137
Total calcium level test
A blood test that measures the total amount of calcium in your body.
125 $5 $26
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
94 $28 $94
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
87 $10 $41
Tuberculosis test, enumeration of t-cells
A blood test that counts T-cells to help detect tuberculosis infection.
80 $97 $175
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
79 $21 $84
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
79 $1 $28
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
60 $49 $250
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
49 $28 $58
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
37 $51 $190
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
31 $13 $54
LDL cholesterol level test
A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol.
30 $10 $25
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
30 $16 $52
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
27 $29 $35
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
24 $4 $20
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
22 $73 $75
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
20 $13 $57
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
19 $9 $75
Iron level test 18 $6 $24
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
18 $8 $27
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
17 $6 $30
Autoimmune disorder screening test
A laboratory test used to screen for the presence of autoimmune disorders.
17 $12 $52
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
16 $13 $73
Rheumatoid factor analysis 15 $6 $54
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
13 $14 $67
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $129 $319
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.2% high complexity
66.3% medium
6.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$204,185
Total received (2018-2024)
Avg $29,169/year across 7 years
Top 5% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
833
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195,324 (95.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,586 (3.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,275 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,389
2023
$34,063
2022
$35,973
2021
$14,763
2020
$25,528
2019
$50,973
2018
$26,495

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$14,161
Amgen Inc.
$1,353
Janssen Biotech, Inc.
$224
Novartis Pharmaceuticals Corporation
$102
UCB, Inc.
$99
AstraZeneca Pharmaceuticals LP
$82
E.R. Squibb & Sons, L.L.C.
$60
GENZYME CORPORATION
$45
Kiniksa Pharmaceuticals International, plc
$44
PFIZER INC.
$30
GlaxoSmithKline, LLC.
$30
Organon Llc
$29
Celgene Corporation
$24
SCILEX PHARMACEUTICALS INC.
$21
Fresenius Kabi USA, LLC
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
SOBI, INC
$16
Sandoz Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 96.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$62,028
Amgen Inc.
$37,304
AbbVie, Inc.
$37,012
AbbVie Inc.
$24,731
Celgene Corporation
$21,709
Regeneron Healthcare Solutions, Inc.
$12,990
GlaxoSmithKline, LLC.
$2,349
Janssen Biotech, Inc.
$1,703
PFIZER INC.
$1,182
E.R. Squibb & Sons, L.L.C.
$513
Boehringer Ingelheim Pharmaceuticals, Inc.
$406
AstraZeneca Pharmaceuticals LP
$402
Janssen Scientific Affairs, LLC
$267
Novartis Pharmaceuticals Corporation
$251
Lilly USA, LLC
$211
GENZYME CORPORATION
$169
UCB, Inc.
$167
Horizon Therapeutics plc
$158
Genentech USA, Inc.
$155
Aurinia Pharma U.S., Inc.
$151
Actelion Pharmaceuticals US, Inc.
$107
Fresenius Kabi USA, LLC
$62
Kiniksa Pharmaceuticals International, plc
$44
Organon Llc
$29
SCILEX PHARMACEUTICALS INC.
$21
Regeneron Pharmaceuticals, Inc.
$19
SOBI, INC
$16
Sandoz Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 66.8% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · JARDIANCE · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · OFEV · ORENCIA · Otezla · Prolia · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · XALATAN · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for rheumatology in NC.

Looking for a rheumatology specialist in Asheville?
Compare rheumatologists in the Asheville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
16
Per 100K population
5.9
County median income
$70,578
Nearest hospital
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gowin is a mixed practice specialist, with above-average Medicare volume (top 20% in NC), with speaking/promotional industry engagement in the top 5% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gowin experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Gowin performed 54,200 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gowin receive payments from pharmaceutical companies?
Yes. Dr. Gowin received a total of $204,185 from 29 companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gowin's costs compare to other rheumatologists in Asheville?
Dr. Gowin's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gowin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →